A convertible loan agreement provides funding initially as a loan, with conversion into equity under agreed conditions. In Germany, this instrument is frequently called a Wandeldarlehen. It can help a startup raise capital before a priced round, but it does not eliminate valuation negotiations. Instead, parties allocate future pricing risk through a discount, valuation cap, conversion triggers and a definition of the share capital used in the calculation. The legal mechanics matter as much as the headline terms. A German GmbH cannot simply issue shares by copying the conversion language of a foreign template. Corporate approvals, subscription formalities and the drafting of the loan must work together. This article considers the position as at 27 July 2026 and distinguishes illustrative commercial calculations from transaction-specific legal requirements.

Before conversion, the investor generally holds contractual claims under the loan rather than an ordinary shareholding created by that instrument. The agreement determines interest, maturity, ranking and conversion rights. Existing shareholder status may give the investor separate rights, but lending alone should not be confused with acquiring all the governance rights of an equity investor. At conversion, the agreed claim is translated into shares through the required corporate process. The agreement should identify the event that activates conversion, who must act and what happens if the process is not completed. A qualified financing round is one possible trigger, usually defined by criteria such as the amount of new money raised. A sale, maturity date or non-qualified round may require different treatment. The commercial purpose is often to fund progress until a larger investment can establish a share price. That can reduce the need to negotiate a full priced equity round immediately. However, deferral is valuable only if it resolves a real timing problem. Where the business has no plausible route to a qualifying round, the instrument may merely accumulate an obligation that becomes difficult to settle. Both founders and investors should examine the agreement as a complete sequence. Funding, interest accrual, conversion, shareholder accession and exit treatment are connected. A convenient signing process is not evidence that the later corporate steps will be straightforward.

Germany’s startup financing ecosystem includes private investors and public-backed programmes, but the availability of capital does not standardise the legal terms of a convertible loan. The OECD’s 2025 review of German venture-capital support describes a varied institutional landscape. Companies may therefore encounter different investor practices even when they use the same instrument name. For a GmbH, statutory corporate formalities remain relevant. Section 53 of the GmbHG requires notarisation of a resolution amending the articles, and Section 55 addresses subscription in a capital increase. Those rules should be distinguished from the separate question of the form required for the convertible loan agreement itself. The answer to that question depends on the commitments contained in the document and the applicable legal analysis. Orrick’s September 2024 checklist and FGVW’s August 2023 discussion identify uncertainty surrounding convertible-loan formalities, including the implications of a regional court decision. That makes a blanket statement that all German convertible loans can be signed informally unsafe. It would also be inaccurate to treat notarial certification of a signature and notarisation of an agreement as the same act. The practical response is to resolve form requirements before funds move. Counsel should review conversion commitments, shareholder participation and any obligation to accede to another agreement. Copying a foreign SAFE or a prior company’s loan can leave material differences in corporate structure and documentation unaddressed.

A discount reduces the conversion price relative to the price paid by new investors in the qualifying round. A valuation cap limits the valuation reference used for conversion, subject to the agreement’s capitalisation definition. Where both apply, documents often give the lender the more favourable resulting price, but the contract must establish the interaction. They should not automatically be applied cumulatively. Consider a simplified company with 100,000 existing fully diluted share units and a new round priced at a €10 million pre-money valuation. The round price is €100 per unit. A 20% discount produces an €80 conversion price. If the agreement also provides a €6 million cap using the same 100,000-unit denominator, the cap price is €60. Where the lower price governs, a €600,000 converting claim produces 10,000 units, before the new round’s shares are issued. That calculation is illustrative and uses economic share units rather than a proposed GmbH capital-increase document. Real outcomes depend on whether the denominator includes option pools, other convertibles, warrants or newly created shares. A post-money cap can allocate dilution differently from a pre-money cap. The label alone is insufficient without the definition and formula. Interest can also convert. A €500,000 loan accruing simple interest at 6% annually for 18 months generates €45,000 of interest, giving a €545,000 converting claim if the agreement includes all accrued interest. Day-count rules, compounding and rounding can change the result. The capitalisation model should reconcile the contractual claim to the shares actually created.

Maturity deserves the same attention as conversion pricing. If no qualifying financing occurs, the agreement may require repayment, permit an extension or provide a separate conversion mechanism. A startup that has spent the loan on development may be unable to repay in cash. The parties should decide how that scenario is handled before it becomes a distressed negotiation. Ranking affects both investor risk and the company’s financial position. German convertible documentation may contain a qualified subordination clause, but its consequences depend on precise drafting and legal effectiveness. A provision intended to address over-indebtedness analysis is not a general cure for liquidity problems, and it does not remove management’s duties to monitor financial distress. Contractual subordination and statutory treatment of shareholder loans are also distinct questions. The investor’s economic protection can extend beyond the cap and discount. Information rights, restrictions on additional borrowing and most-favoured-nation provisions can influence subsequent fundraising. A clause allowing an early lender to adopt later favourable terms may reduce flexibility when the company needs a new bridge on different economics. Founders should assess the combined stack of convertibles. Several individually modest loans can convert into a substantial shareholding when discounts, caps and accrued interest interact. The next equity investor will evaluate the resulting capital structure, including how much new money reaches the company and how existing claims rank before conversion. Deferring a priced round does not defer the need for disciplined dilution modelling.

Business angels, venture funds and existing shareholders may all provide convertible financing, but their objectives can differ. An existing investor may fund a short bridge to protect an earlier investment. A new investor may use the instrument to secure access to a future round. Those incentives affect conversion triggers, information rights and the response if the expected round does not occur. The borrower’s management needs a clear mandate from the relevant shareholders. Promising future shares without securing the necessary cooperation can create a gap between the contractual intention and the corporate action required to implement it. The agreement should identify the parties whose participation is needed and the process for obtaining approvals. Legal counsel and the notary perform complementary roles. Transaction counsel should connect the economics to the loan, corporate resolutions and shareholder documentation. The notarial process addresses the required formal acts. Tax and accounting advisers should review the specific structure where the treatment of interest, conversion or cross-border investors creates material consequences. The next-round lead investor is another practical stakeholder even before it is identified. It may require outstanding loans to convert and may object to inconsistent side rights. Clean records and a consolidated model help prevent that issue from delaying a financing. A short bridge can become expensive if it creates a disproportionate documentation problem at the next round.

The company should begin with a reconciled capitalisation table and a schedule of every outstanding convertible, warrant and relevant option commitment. Conversion should be modelled at several round valuations, including one below the cap, one between the cap and discount crossover, and one above it. A no-round case and a sale before conversion should be modelled separately. Definitions should receive particular scrutiny. New money may exclude amounts converted from existing loans, while the qualified-round threshold can be sensitive to that distinction. The treatment of an option-pool increase can shift dilution among founders, convertible investors and new shareholders. A calculation should reproduce the agreement’s actual definitions rather than a simplified investor presentation. Execution planning should connect signing, funding, approvals and conversion. Where lender obligations or shareholder accession raise form issues, those should be resolved before using an electronic signature process. Subsequent conversion does not necessarily repair every earlier defect or eliminate the consequences of an invalid clause during the intervening period. The board should also define the commercial limit of the bridge. If the planned milestone slips, a further convertible may increase both the repayment exposure and the dilution burden. Revisiting a priced equity round can be more constructive than repeatedly extending a stack whose conversion terms have become difficult to explain. Simplicity should be measured across the full financing cycle.

A well-structured German convertible loan can solve a genuine timing problem between investment need and a priced equity round. Its effectiveness depends on transparent conversion economics, workable maturity provisions and legally coherent implementation. The cap and discount attract attention, but the capitalisation definition, interest treatment and required corporate acts often determine the actual outcome. Founders should therefore negotiate the instrument with both the next round and the no-round case in view. A model that reconciles every claim to its eventual shareholding, combined with early review of German form and subordination issues, makes the financing easier to understand and execute. Deferring valuation should preserve flexibility rather than obscure future obligations.

The agreement determines their interaction. Often the investor receives the lower conversion price produced by the cap or the discount, rather than applying both cumulatively. The fully diluted capitalisation definition can materially alter the result, so the economic model should use the contractual formula and the complete outstanding financing stack.

The required form depends on the agreement’s contents and structure. German legal commentary identifies uncertainty around particular conversion obligations and related commitments. Separate formalities also apply to a GmbH capital increase. The company should obtain transaction-specific advice before signing, rather than assume that an informal or electronic signature is sufficient.

The maturity and fallback provisions govern. Repayment, extension or conversion on a separate basis may be contemplated, but none should be assumed. A company should model the cash consequences of maturity and ensure that the agreement’s treatment of a missing financing round is clear before accepting the loan.